Treatment of acute coronary syndrome: Part 1: Non-ST-segment acute coronary syndrome

Critical Care Medicine

Volumn 39, Issue 10, 2011, Pages 2346-2353

  Trost, Jeffrey C ^a   Lange, Richard A ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

acute coronary syndrome; acute myocardial infarction; coronary artery disease; unstable angina

Indexed keywords

ACETYLSALICYLIC ACID; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; ENOXAPARIN; GLYCERYL TRINITRATE; HEPARIN; HIRULOG; MORPHINE; PLACEBO; PRASUGREL; TROPONIN I; TROPONIN T;

ACUTE CORONARY SYNDROME; ANGIOCARDIOGRAPHY; CLINICAL FEATURE; CONSERVATIVE TREATMENT; CRITICALLY ILL PATIENT; DIFFERENTIAL DIAGNOSIS; ELECTROCARDIOGRAM; HEART CATHETERIZATION; HUMAN; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; UNSTABLE ANGINA PECTORIS;

EID: 80052969239     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e31821e855f     Document Type: Review

References (41)

1. Anderson JL, Adams CD, Antman EM, et al: ACC/AHA 2007 Guidelines for the management of patients with unstable angina/non-ST Segment elevation myocardial infarction: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. Circulation 2007; 116:e148-e304
2. Lloyd-Jones D, Adams R, Brown TM, et al: Heart disease and stroke statistics-2010 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2010; 121:948-954
3. Alpert JS, Thygesen K, Antman E, et al: Myocardial infarction redefined: A consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000; 36: 959-969
4. Fromm RE: Cardiac troponins in the intensive care unit: Common causes of increased levels and interpretation. Crit Care Med 2007; 35:584-588
5. Lim W: Cardiac troponin in the intensive care unit. Clin Invest Med 2009; 32:E405-E410
6. Guest TM, Ramanathan AV, Tuteur PG, et al: Myocardial injury in critically ill patients. JAMA 1995; 273:1945-1949
7. Noble JS, Reid AM, Jordan LVM, et al: Troponin I and myocardial injury in the ICU. Br J Anaesth 1999; 82:41-46 (Pubitemid 29043126)
8. Ammann P, Maggiorini M, Bertel O, et al: Troponin as a risk factor for mortality in critically ill patients without acute coronary syndromes. J Am Coll Cardiol 2003; 441: 2004-2009 (Pubitemid 36677123)
9. Quenot JP, Le Teuff G, Quantin C, et al: Myocardial injury in critically ill patients: relation to increased cardiac troponin I and hospital mortality. Chest 2005; 128:2758-2764 (Pubitemid 41507637)
10. King DA, Codish S, Novack V, et al: The role of cardiac troponin I as a prognosticator in critically ill medical patients: A prospective observational cohort study. Crit Care 2005; 9:R390-395
11. Wu TT, Yuan A, Chen CY, et al: Cardiac troponin I levels are a risk factor for mortality and multiple organ failure in noncardiac critically ill patients and have an additive effect to the APACHE II score in outcome prediction. Shock 2004; 22:95-101 (Pubitemid 40228185)
12. Stein R, Gupta B, Agarwal S, et al: Prognostic implications of normal and borderline troponin elevation levels in critically ill patients without acute coronary syndrome. Am J Cardiol 2008; 102:509-512
13. Sabatine MS, Antman EM: The Thrombolysis in Myocardial Infarction risk score in unstable angina/non-ST-segment elevation myocardial infarction. J Am Coll Cardiol 2003; 41(Suppl S):89S-95S (Pubitemid 36223352)
14. Antman EM, Cohen M, Bernink PJ, et al: The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making. JAMA 2000; 284:835-842 (Pubitemid 30643610)
15. Eagle KA, Lim MJ, Dabbous OH, et al: A validated prediction model for all forms of acute coronary syndrome: Estimating the risk of 6-month post discharge death in an international registry. JAMA 2004; 291: 2727-2733 (Pubitemid 38725422)
16. de Araú jo Gonçalves P, Ferreira J, Aguiar C, et al: TIMI, PURSUIT, and GRACE risk scores: Sustained prognostic value and interaction with revascularization in NSTE-ACS. Eur Heart J 2005; 26:865-872 (Pubitemid 40676566)
17. Subherwal S, Bach RG, Chen AY, et al: Baseline risk of major bleeding in non-STsegment elevation myocardial infarction: The CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines) bleeding score. Circulation 2009; 119:1873-1882
18. Lewis HD, Davis JW, Archibald DG, et al: Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. N Engl J Med 1983; 309: 396-403
19. Theroux P, Ouimet H, McCans J, et al: Aspirin, heparin or both to treat unstable angina. N Engl J Med 1988; 319:1105-1111
20. Cairns JA, Gent M, Singer J, et al: Aspirin, sulfinpyrazone, or both in unstable angina: Results of a Canadian multicenter trial. N Eng J Med 1985; 313:1369-1375 (Pubitemid 16211835)
21. RISC Group: Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery disease. Lancet 1990; 336:827-830
22. Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001; 345:494-502
23. Mehta SR, Yusuf S, Peters RJ, et al: Clopidogrel in Unstable angina to prevent Recurrent Events trial (CURE) Investigators. Effects of pretreatment with clopidogrel and aspirin followed by long term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet 2001; 358:527-533 (Pubitemid 32772726)
24. Steinhubl SR, Berger PB, Mann JT III, et al: CREDO Investigators. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: A randomized controlled trial. JAMA 2002; 288: 2411-2420 (Pubitemid 35340537)
25. Wiviott SD, Braunwald E, McCabe CH, et al: TRITON-TIMI 38 Investigators. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 2007; 375: 2001-2015 (Pubitemid 350106708)
26. Boersma E, Harrington RA, Moliterno DJ, et al: Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: A meta-analysis of all major randomized clinical trials. Lancet 2002; 359:189-198 (Pubitemid 34113814)
27. Klottwijk P, Meij S, Melkert R, et al: Reduction of recurrent ischemia with abciximab during continuous ECG-ischemia monitoring in patients with unstable angina refractory to standard treatment (CAPTURE). Circulation 1998; 98:1358-1364 (Pubitemid 28462794)
28. Platelet Receptor Inhibition for Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISMPLUS) Trial Investigators: Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction. N Engl J Med 1998; 338:1488-1497
29. The PURSUIT Trial Investigators: Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes. N Engl J Med 1998; 339:436-443
30. Antman EM, McCabe CH, Gurfinkel EP, et al: Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction: Results of the Thrombolysis in Myocardial Infarction (TIMI) 11B trial. Circulation 1999; 100:1593-1601 (Pubitemid 29477267)
31. De Lemos JA, Blazing MA, Wiviott SD, et al: A to Z Investigators. Enoxaparin versus unfractionated heparin in patients treated with tirofiban, aspirin and an early conservative initial management strategy: results from the A phase of the A-to-Z trial. Eur Heart J 2004; 25:1688-1694 (Pubitemid 39286633)
32. Ferguson JJ, Califf RM, Antman EM, et al: SYNERGY Trial Investigators. Enoxaparin vs unfractionated heparin in high-risk patients with non-ST segment elevation acute coronary syndromes managed with an intended early invasive strategy: Primary results of the SYNERGY randomized trial. JAMA 2004; 292: 45-54
33. Yusuf S, Mehta SR, Chrolavicius S, et al: Comparison of fondaparinux and enoxaparin in acute coronary syndromes. N Engl J Med 2006; 354:1464-1476
34. Stone GW, McLaurin BT, Cox DA, et al: Bivalirudin for patients with acute coronary syndromes. N Engl J Med 2006; 355: 2203-2216 (Pubitemid 44791162)
35. LIPID Study Group: Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med 1998; 339:1349-1357
36. Cannon CP, Braunwald E, McCabe CH, et al: PROVE IT-TIMI 22 Investigators. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 2004; 350:1495-1504 (Pubitemid 38477774)
37. Neumann FJ, Kastrati A, Pogatsa-Murray G, et al: Evaluation of prolonged antithrombotic pretreatment ('cooling-off' strategy) before intervention in patients with unstable coronary syndromes: A randomized controlled trial. JAMA 2003; 290:1593-1599 (Pubitemid 37441261)
38. van't Hof AW, de Vries ST, Dambrink JH, et al: A comparison of two invasive strategies in patients with non-ST elevation acute coronary syndromes: results of the Early or Late Intervention in unStable Angina (ELISA) pilot study. 2b/3a upstream therapy and acute coronary syndromes. Eur Heart J 2003; 24: 1401-1405 (Pubitemid 36961829)
39. Riezebos RK, Ronner E, Ter Bals E, et al: OPTIMA trial. Immediate versus deferred coronary angioplasty in non-ST-segment elevation acute coronary syndromes. Heart 2009; 95:807-812
40. Mehta SR, Granger CB, Boden WE, et al: Early versus delayed invasive intervention in acute coronary syndromes. N Engl J Med 2009; 360:2165-2175
41. Montalescot G, Cayla G, Collet JP, et al: Immediate vs delayed intervention for acute coronary syndromes: A randomized clinical trial. JAMA 2009; 302:947-954